Indian Patent Office rejects Pfizer's claim for arthritis drug patent

07 Sep 2015

The Indian Patent Office has rejected a patent application by pharma multinational Pfizer Inc for its rheumatoid arthritis drug `Tofacitinib’ for failing to prove its efficacy over its original version for which patent protection is ending

Cipla to acquire 100% stake in two US generic drug firms for $550 mn

04 Sep 2015

Cipla, a global major in generic pharmaceuticals, today announced the acquisition of two US-based generic drug companies,aimed at strengthening its marketing network

US FDA approves AstraZeneca’s new dosage for heart drug 'Brilinta'

04 Sep 2015

Canada’s Valeant Pharmaceuticals to acquire surgical device maker Synergitics

03 Sep 2015

Valeant to buy rights to AstraZeneca's psoriasis drug

01 Sep 2015

Drugmaker Bristol-Myers Squibb acquires rights to Promedior Inc and its experimental drug PRM-151

01 Sep 2015

Godrej Agrovet to buy 45.29% in Astec LifeSciences

31 Aug 2015

Following the deal, Godrej Agrovet will make a mandatory open offer to the shareholders of Astec LifeSciences

Mylan shareholders back plan for Perrigo hostile bid

29 Aug 2015

Leave drug pricing to fair competition, Cipla chief tells govt

28 Aug 2015

Germany suspends more drugs tested by GVK Bio

22 Aug 2015

Despite the ban, the German regulator said it has no information so far that the medicines subjected to clinical trials by GVK Bio posed any health risks to patients

View details about the software product Informachine News Trackers